Article info

Download PDFPDF

Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome

Authors

  • Mizuki Nishino Department of RadiologyBrigham and Women’s Hospital and Dana-Farber Cancer Institute 450 Brookline Avenue 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Anita Giobbie-Hurder Department of Biostatistics and Computational BiologyDana-Farber Cancer Institute 450 Brookline Avenue 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Nikhil H Ramaiya Department of RadiologyBrigham and Women’s Hospital and Dana-Farber Cancer Institute 450 Brookline Avenue 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • F Stephen Hodi Department of Medical Oncology and Department of MedicineDana-Farber Cancer Institute and Brigham and Women’s Hospital 450 Brookline Avenue 02215 Boston MA USA PubMed articlesGoogle scholar articles
  1. a Mizuki_Nishino{at}DFCI.HARVARD.EDU
  2. b agiohur{at}jimmy.harvard.edu
  3. c NR988{at}partners.org
  4. d Stephen_Hodi{at}dfci.harvard.edu
View Full Text

Citation

Nishino M, Giobbie-Hurder A, Ramaiya NH, et al
Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome

Publication history

  • Received September 15, 2014
  • Accepted October 28, 2014
  • First published November 18, 2014.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.